Our World

Contact Us

Press Releases

Biocon Biologics / Press Releases

Mylan and Biocon Present Clinical Data on Insulin Glargine at the American Diabetes Association’s 77th Scientific Sessions

Sun, 11-Jun-2017
Posted by: Biocon Biologics

Biocon Appoints Ms. Pratima Rao as Mission Director of Biocon Foundation

Mon, 05-Jun-2017
Posted by: Biocon Biologics

Kiran Mazumdar Shaw Felicitated with ‘AWSM Award for Excellence 2017’ by The Feinstein Institute for Medical Research, USA

Fri, 05-May-2017
Posted by: Biocon Biologics

Biocon Q4 FY17 Revenue Rs 974 Cr; Net Profit Rs 127 Cr; FY17 Revenue at Rs 4,079 Cr; Net Profit at Rs 612 Cr

Thu, 27-Apr-2017
Posted by: Biocon Biologics

U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon’s Proposed Biosimilar Pegfilgrastim for Review

Thu, 16-Feb-2017
Posted by: Biocon Biologics

Biocon Foundation & Department of Medical, Health & Family Welfare, Govt. of Karnataka Collaborate to Set Up Smart eLAJ Clinics in Karnataka

Tue, 07-Feb-2017
Posted by: Biocon Biologics

Biocon Wins MYR 300 Million Contract for Insulin from MoH, Malaysia

Wed, 25-Jan-2017
Posted by: Biocon Biologics

Biocon Q3 FY17 Net Profit Up 65% at Rs 171 Crore Revenue Rises 32% at Rs 1092 Crore; EBITDA Increases 57% to Rs 324 Crore

Tue, 24-Jan-2017
Posted by: Biocon Biologics

U.S. FDA Accepts Biologics License Application (BLA) for Mylan and Biocon’s Proposed Biosimilar Trastuzumab

Wed, 11-Jan-2017
Posted by: Biocon Biologics

Journal of the American Medical Association (JAMA) Publishes Mylan and Biocon’s Proposed Biosimilar Trastuzumab Phase 3 Data

Tue, 27-Dec-2016
Posted by: Biocon Biologics

1
…
16
17
18
19
20

buy twitter followers - omegle - matadorbet güncel adres - onwin - onwin güncel adres